Skip to content

Clinical trials

Diffuse Intrinsic Pontine Glioma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diffuse Intrinsic Pontine Glioma Country / region: Australia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20191
20201
20212
20222
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Completed2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nationwide Children's Hospital5
Aminex Therapeutics, Inc.1
Cellectar Biosciences, Inc.1
Children's Oncology Group1
Eli Lilly and Company1
National Cancer Institute (NCI)1
Rigel Pharmaceuticals1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diffuse Intrinsic Pontine Glioma12
Glioma9
Glioblastoma6
Astrocytoma5
Brain Neoplasms4
Ependymoma2
Gliosarcoma2
Lymphoma2
Medulloblastoma2
Neuroblastoma2

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.